These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 6151151

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects.
    Sonnenberg GE, Keller U, Perruchoud A, Burckhardt D, Gyr K.
    Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898
    [Abstract] [Full Text] [Related]

  • 4. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
    Bosch J, Kravetz D, Rodes J.
    Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
    [Abstract] [Full Text] [Related]

  • 5. Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis.
    Merkel C, Gatta A, Caregaro L, Sacerdoti D, Rondana M, Ruol A.
    Scand J Clin Lab Invest; 1987 Nov; 47(7):667-72. PubMed ID: 2891182
    [Abstract] [Full Text] [Related]

  • 6. Effects of bolus injections and continuous infusions of somatostatin and placebo in patients with cirrhosis: a double-blind hemodynamic investigation.
    Cirera I, Feu F, Luca A, García-Pagán JC, Fernández M, Escorsell A, Bosch J, Rodés J.
    Hepatology; 1995 Jul; 22(1):106-11. PubMed ID: 7601400
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of octreotide on systemic, central, and splanchnic haemodynamics in cirrhosis.
    Møller S, Brinch K, Henriksen JH, Becker U.
    J Hepatol; 1997 May; 26(5):1026-33. PubMed ID: 9186833
    [Abstract] [Full Text] [Related]

  • 9. Influence of somatostatin on splanchnic haemodynamics in patients with liver cirrhosis.
    Eriksson LS, Law DH, Sato Y, Wahren J.
    Clin Physiol; 1984 Feb; 4(1):5-11. PubMed ID: 6141861
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Changes of hepatic and systemic haemodynamics following somatostatin administration in patients with hepatitis B-related cirrhosis.
    Hsia HC, Lin HC, Lee FY, Tsai YT, Lee SD, Meng HC, Chao Y, Wang SS, Lo KJ.
    J Gastroenterol Hepatol; 1993 Feb; 8(1):15-20. PubMed ID: 8094983
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The calcium-channel blocker, verapamil, does not improve portal pressure in patients with alcoholic cirrhosis.
    Merkel C, Gatta A, Bolognesi M, Padrini R, Finucci GF, Angeli P, Ruol A.
    Br J Clin Pharmacol; 1988 Sep; 26(3):273-7. PubMed ID: 3179167
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immediate effects of different schedules of somatostatin on portal pressure in patients with liver cirrhosis.
    Zhang C, Xu JM, Kong DR, Min XK, Chen R.
    J Clin Pharm Ther; 2013 Jun; 38(3):206-11. PubMed ID: 23437909
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.